SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The role of registries in hematological disorders.

Baldomero, H; Neumann, D; Hamad, N; Atsuta, Y; Sureda, A; Iida, M; Karduss, A; Elhaddad, AM; Bazuaye, NG; Bonfim, C; et al. Baldomero, H; Neumann, D; Hamad, N; Atsuta, Y; Sureda, A; Iida, M; Karduss, A; Elhaddad, AM; Bazuaye, NG; Bonfim, C; Camara, RDL; Chaudhri, NA; Ciceri, F; Correa, C; Frutos, C; Galeano, S; Garderet, L; Greco, R; Jaimovich, G; Kodera, Y; Koh, MB; Liu, K; Ljungman, P; McLornan, DP; Nair, G; Okamoto, S; Pasquini, MC; Passweg, J; Paulson, K; Ruggeri, A; Seber, A; Snowden, JA; Srivastava, A; Worel, N; Saber, W; Rondelli, D; Aljurf, M; Niederwieser, D; Worldwide Network of Blood and Marrow Transplantation (2024) The role of registries in hematological disorders. Best Pract Res Clin Haematol, 37 (2). p. 101556. ISSN 1521-6926 https://doi.org/10.1016/j.beha.2024.101556
SGUL Authors: Koh, Mickey

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

Hematopoietic cell transplantation (HCT) was developed more than 65 years ago to treat malignant blood disorders and irreversible bone marrow failures, with the aim of replacing a diseased hematopoietic system with a healthy one (allogeneic HCT). Decades later, the procedure was adapted to apply maximal chemotherapy or radiotherapy, which would result in bone marrow failure, but could be remedied by an infusion of a patient's own cryopreserved bone marrow (autologous HCT). Both treatments are high-risk and complex, especially during the initial phases. However, concerted efforts, vision, and collaboration between physicians and centers worldwide have resulted in HCT becoming a standard of care for many hematological disorders with progressive improvements in outcomes. Registries and the collaboration of societies worldwide have enabled the delivery of this curative therapy to many patients with fatal hematological diseases. More than 1.5 million HCT were performed between 1957 and 2019, and activity is continuously increasing worldwide.

Item Type: Article
Additional Information: © 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Allogeneic HCT, Autologous HCT, Hematopoietic cell transplantation (HCT), Leukemia, Outcome registry, Registries, Survey, Humans, Registries, Hematopoietic Stem Cell Transplantation, Hematologic Diseases
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical, Biomedical and Allied Health Education (IMBE)
Journal or Publication Title: Best Pract Res Clin Haematol
ISSN: 1521-6926
Language: eng
Media of Output: Print-Electronic
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDUniversitat LeipzigUNSPECIFIED
PubMed ID: 39098798
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/117449
Publisher's version: https://doi.org/10.1016/j.beha.2024.101556

Statistics

Item downloaded times since 24 Apr 2025.

Actions (login required)

Edit Item Edit Item